RMTI

Rockwell Medical Inc
NASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC

Key Statistics

Market Cap
$31.16M
P/E Ratio
—
EPS
$-1.34
Beta
1.73
52W High
$12.90
52W Low
$4.88
50-Day MA
$7.89
200-Day MA
$8.15
Dividend Yield
—
Profit Margin
-7.33%
Forward P/E
21.37
PEG Ratio
4.43

About Rockwell Medical Inc

Rockwell Medical, Inc. is a biopharmaceutical company targeting end-stage renal disease and chronic kidney disease with iron deficiency treatment and hemodialysis products and therapies in the United States and internationally. The company is headquartered in Wixom, Michigan.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$69.39M
Gross Profit (TTM)$12.29M
EBITDA$-2.43M
Operating Margin-5.97%
Return on Equity-15.50%
Return on Assets-5.18%
Revenue/Share (TTM)$17.97
Book Value$8.83
Price-to-Book0.89
Price-to-Sales (TTM)0.45
EV/Revenue0.291
EV/EBITDA30.21
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)10.60%
Shares Outstanding$4.03M
Float$3.59M
% Insiders14.78%
% Institutions8.49%

Historical Volatility

HV 10-Day
96.81%
HV 20-Day
79.02%
HV 30-Day
73.44%
HV 60-Day
59.85%
HV Rank
84.5%

Volatility is currently expanding

Analyst Ratings

Consensus ($20.00 target)
1
Strong Buy
1
Buy

Latest News

Vantive Announces Agreement to Divest Majority of Hemodialysis Assets and Associated Operations to Rockwell Medical

Sharpens Vantive's Focus on Home Dialysis and Critical Care DEERFIELD, Ill., Nov. 3, 2026 /PRNewswire/ -- Vantive, a vital organ therapy company with a 70-year legacy of kidney care innovation, today announced that it has entered into a definitive agreement with Rockwell Medical, Inc. (Nasdaq: RMTI) to divest the majority of the assets and associated operations related to Vantive's hemodialysis (HD) business.

PRNewsWire11/3/2026Neutral
Rockwell Medical Announces Second Quarter 2026 Results

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical announces Q2'26 results, delivering strong year-over-year growth, expanding gross margin and generating positive operating cash flow.

Business Wire8/13/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on RMTI and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 11/7/2026